FDA Chief to Resign Next Month After Successful Tenure


"All of us at HHS are proud of the remarkable work Commissioner Gottlieb has done at the FDA", he said.

Gottlieb's successor is unknown. In early February, the FDA pursued enforcement actions against some Walgreen and Circle K locations.

"It's my belief that we've been successful in this country at stigmatizing tobacco products among kids", Gottlieb said in April. "While I'm confident the leaders he empowered will carry on that work, and we wish Scott the best, there's no doubt he'll be missed and hard to replace".

In April, Gottlieb told CNN Chief Medical Correspondent Dr. Sanjay Gupta that opioids are the biggest crisis facing the FDA. "While Gottlieb had some policy disagreements with the White House, he is well respected, and could even be invited back to another post, two officials said".

U.S. Food and Drug Administration Commissioner Scott Gottleib (L), Sen.

Following news of Mr Gottlieb's resignation, the Nasdaq Biotechnology Index turned negative. Similarly, shares of Amgen Inc erased their gains and Gilead Sciences Inc shares added to losses.

Beyond that, new pathways for novel devices were created, including "modernizations of the 510 (k) process", he said. "That just happened to be one of them". (NYSE: MO), British American Tobacco PLC (NYSE: BTI) and Philip Morris International, Inc.

Scott Melville, President and CEO of the Consumer Healthcare Products Association (CHPA), issued the following statement: "Commissioner Gottlieb has been a vocal advocate for ensuring consumer access to safe and reliable self-care options including over-the-counter (OTC) medicines and dietary supplements". "One of my growing concerns, we're approving a lot of drugs, but not seeing a commensurate number of drugs launched", he said at the time.

'Over the past 23 months, I've been privileged to work with an outstanding team at the Food and Drug Administration, and to collaborate with the professional staff on implementation of many meaningful incentives that have advanced the public health.

Under Dr Gottlieb, the FDA proposed a ban on the sale of fruit- and candy-flavored electronic cigarettes in convenience stores and gas stations. His departure coincided with pushback from Congress and conservative circles against the FDA's aggressive efforts to crack down e-cigarette sales. Mr Trump said on Twitter on Tuesday.

President Donald Trump weighed in on Gottlieb's pending resignation Tuesday.

As an industry insider, the selection of Gottlieb was originally both lauded and criticized when he first took the post in 2017. Prior to his role with the FDA, he worked as clinical assistant professor at the New York University School of Medicine, FDA Deputy Commissioner for Medical and Scientific Affairs, and as a venture partner with New Enterprise Associates. At the time, his nomination drew strong criticism for his ties to the pharmaceutical and biotech industries.